Stefan Wirths

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma

Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome

Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program

High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: An open-label, non-inferiority phase 2 trial

Chronic Lymphocytic Leukemia Research

Lymphoma Diagnosis and Treatment

Immunotherapy and Immune Responses

T-cell and B-cell Immunology

Chronic Myeloid Leukemia Treatments